...
首页> 外文期刊>National Academy Science Letters >A Breakthrough on Cancer Therapy by Inhibition of Negative Immune Regulation: Nobel Prize in Physiology or Medicine 2018
【24h】

A Breakthrough on Cancer Therapy by Inhibition of Negative Immune Regulation: Nobel Prize in Physiology or Medicine 2018

机译:抑制负面免疫调节癌症治疗的突破:2018年生理学或医学奖项

获取原文
获取原文并翻译 | 示例
           

摘要

James P. Allison from the MD Anderson Cancer Center, University of Texas, and Tasuku Honjo from Kyoto university were jointly awarded the prestigious Nobel Prize in Physiology/Medicine 2018. Their therapeutic research is on the inhibition of CTLA-4 and PD-1, two proteins which act as a blockade and prevent the immune system from attacking tumor cells.
机译:来自德克萨斯大学的MD Anderson癌症中心的詹姆斯··艾莉森和京都大学的Tasuku Honjo共同授予着名的诺贝尔2018年生理学/医学奖。其治疗研究是对CTLA-4和PD-1的抑制作用, 两种蛋白质充当阻断并防止免疫系统攻击肿瘤细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号